Publications by authors named "J P Roperch"

Claim this Profile
M
Multiple highly methylated CpG sites as potential epigenetic markers for the diagnosis of prostate cancer.
Jean-Pierre Roperch, Guillaume Charbonnier, Sandy Figiel, Alastair Lamb, Ian Mills

Clin Epigenetics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients - Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC).
Jean-Pierre Roperch, Claude Hennion

BMC Med Genet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer.
Julien Peltier, Jean-Pierre Roperch, Stéphane Audebert, Jean-Paul Borg, Luc Camoin

Clin Proteomics· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Julien Peltier, Jean-Pierre Roperch, Stéphane Audebert, Jean-Paul Borg, Luc Camoin

J Proteomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Jean-Pierre Roperch, Bernard Grandchamp, François Desgrandchamps, Pierre Mongiat-Artus, Vincent Ravery

BMC Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis